Quintiles has expanded its capabilities to include anatomic pathology services through its central lab in Beijing, China, in an effort to help biopharmaceutical companies develop more effective cancer treatments. These services complement assay development, digital pathology and core lab offerings available through the facility to help customers comply with China’s restrictions on tissue import/export. “Within China, we are providing the tools and infrastructure to investigate cancer and matc...